Oura to acquire AI primary care start-up Counsel Health for $625M in cash
TLDR
- Oura agreed to buy AI primary care start-up Counsel Health for $625M in cash, funded from its own resources.12
- Counsel had raised about $36M, so the price is over 17 times that; investor proceeds were not disclosed.23
- Outlets disagree on close timing: the release says year-end, TechCrunch says 2027; Counsel's valuation was not disclosed.14
Oura, the smart-ring maker, said on 10 November that it had signed a definitive agreement to acquire Counsel Health, "an AI-native primary care company", for "$625 million in cash, subject to purchase price adjustments", with closing expected "before the end of the calendar year" subject to customary conditions.1 Fierce also reports a year-end close, but TechCrunch's deal article says "before the end of 2027", which looks like an error and was not resolved.54 Oura chief executive Tom Hale told STAT "we're paying for this out of our own pocket"; STAT noted Oura's IPO filing showed $372M in cash at the end of June, less than the price.2 Quartz, citing Bloomberg, says Hale called it Oura's largest purchase "by multiples".6 The release gives preliminary, unaudited results of $533M revenue for the September quarter, up 153%, with $87M adjusted EBITDA, and about $1.75B revenue for 2026; it cites "over six million members", while Fierce counts 5.7 million paid members.15
Counsel "combines medical AI with in-house physicians to deliver immediate, high-quality guidance and care", selling to health plans, health systems, digital health companies, employers and consumers.1 Its platform is "a clinical AI harness that invokes specialized agents for tasks such as medical history-taking, guideline retrieval, records review, and emergency detection", with physicians working in a proprietary "Clinician Cockpit".1 Chief executive Muthu Alagappan, a physician and former chief medical officer of Notable Health, wrote that Counsel started in 2023, reports an 80 net promoter score and a two-minute average physician response, and is available to more than 8 million Americans through partnerships; these are company figures.7 The release adds that over 90% of surveyed members said their Oura data helped them get better care and that members rated physician care 4.6 out of 5, with no sample size given.1 Quartz, from Bloomberg, says Alagappan becomes chief clinical AI officer, with about 70 employees and 50 on-demand physicians joining; that is second-hand.6 STAT places Counsel's offices in Boston and New York, while MedCity says Boston.28 a16z calls Counsel "the fastest way to get Eli Lilly GLP-1 treatment", and STAT notes that Lilly has also invested in Oura; Trending Topics puts that stake at a $50M convertible instrument.923
Counsel's backers are the usual early-stage health-tech group. Asymmetric Capital Partners says it co-led the pre-seed with Floodgate; the amount and date were not found.10 The $11M seed, announced in October 2024, was led by a16z Bio + Health with Asymmetric, Floodgate and Pear VC.11 The $25M Series A in October 2025 was co-led by a16z and GV, with Asymmetric, Floodgate and Pear.12 TechCrunch says PitchBook estimates $36M raised in total, and STAT says the company had "previously disclosed $36 million".42 Trending Topics writes that the price is "more than 17 times the capital raised", and Flare Capital Partners' Michael Greeley told MedCity "the 17x multiple on invested capital is very compelling".38 That is price over disclosed funding, not an investor return: no source gives Counsel's valuation at any round, ownership stakes or proceeds, the $36M excludes the undisclosed pre-seed, and the release says only that the price is "subject to purchase price adjustments".128 a16z's post congratulates the company and states no price, multiple or proceeds.9
Both lead investors have backed health AI elsewhere. a16z led Telepatia's $33M Series A in June 2026 and Ease's $41M Series A, an AI-native behavioural health company, in March 2026, and led Abridge's $300M Series E in June 2025.131415 GV led the $27M Series A of Translucent AI, a healthcare finance platform, in March 2026.16
For Oura the deal follows a postponed listing. In September it postponed an IPO that sought up to $2.2B, which TechCrunch said valued it at up to $15B at the midpoint and Fortune at $15.6B fully diluted at the top of the range.1718 Its last private round, in October 2025, raised over $900M led by Fidelity at about $11B.19 Hale told Bloomberg there was nothing new to share on a listing, and an Oura spokesperson declined to say how the deal affects its public-market plans.68 Trending Topics names Whoop, Samsung's Galaxy Ring, Ultrahuman, RingConn and Apple Watch as wearable rivals, and OpenAI's ChatGPT Health and Amazon One Medical as alternatives in AI-led care.3 STAT says the deal "reflects a growing desire to connect consumer wearable devices to clinical care as well as the conviction that AI chatbots will be an important part of health care".2
Why it matters: a consumer-hardware company is spending cash on clinical AI after shelving its IPO, which gives a16z, GV and the seed investors an exit, but only the price-to-capital ratio is known, not proceeds, valuation or a settled close date.123
Sources
- Oura to Acquire Counsel Health, Advancing Vision for More Connected, Personalized Healthcare (Business Wire (Oura))
- Oura to acquire Counsel Health for $625 million (STAT (via The Boston Globe))
- Oura Buys Counsel Health for $625 Million (Trending Topics)
- Oura to acquire AI-native primary care startup Counsel Health for $625M (TechCrunch)
- Oura to acquire AI virtual care partner Counsel Health for $625M (Fierce Healthcare)
- Oura to buy Counsel Health, a clinical AI startup, for $625 million (Quartz)
- Counsel Is Being Acquired by Oura to Advance the Future of Care (Counsel Health)
- Oura's Buys Counsel for $625M, But Will Payers and Consumers Get on Board? (MedCity News)
- Counsel Health joins OURA (Andreessen Horowitz (Health Tech Builders))
- Democratizing Care: Announcing our Investment in Counsel Health (Asymmetric Capital Partners)
- Counsel Health Launches with $11M in Seed Funding to Deliver Physician-Led, AI-Powered Medical Advice (PR Newswire (Counsel Health))
- $25M Series A and The Launch of AI Care Platform (Counsel Health)
- Investing in Telepatia (Andreessen Horowitz)
- Investing in Ease (Andreessen Horowitz)
- Abridge Series E Announcement and More (Abridge)
- Translucent AI: Healthcare's Financial OS (GV)
- Oura shelves its $2.2B IPO, citing 'uncertainty' in the market (TechCrunch)
- Why Oura delayed its IPO (Fortune)
- ŌURA Raises Over $900M to Accelerate Global Expansion and Health Innovation (Business Wire (Oura))